Ontology highlight
ABSTRACT: Objectives
In this systematic review, we aim to identify laboratory biomarkers that predict response to tumour necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA).Methods
EMBASE, PubMed and Cochrane Library (CENTRAL) were searched for studies that presented predictive accuracy measures of laboratory biomarkers, or in which these were calculable. Likelihood ratios were calculated in order to determine whether a test result relevantly changed the probability of response. Likelihood ratios between 2-10 and 0.5-0.1 were considered weak predictors, respectively, and ratios above 10 or below 0.1 were considered strong predictors of response. Primary focus was on biomarkers studied ≥3 times.Results
From 41 included studies, data on 99 different bio
SUBMITTER: Wientjes MHM
PROVIDER: S-EPMC9730399 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature